Latest Notices
January 11, 2024 - NOTICE regarding examination requirements and graduate training programs
The Drug Enforcement Administration (DEA) published a final rule, amending the regulations regarding DEA Form 106. Learn more.
Information
Clarification of Opioid Continuing Education Requirement Under ABC-map (PDF)
PA Prescription Drug Monitoring Program Transition Announcement (PDF)
50 State Comparison Report: A Comparison of State Occupational Licensure Requirement and Processes
Act 6 of 2018 Notice to All Licensees, Registrants, Certificate Holders & Permit Holders (PDF)
Notice - Act 65 Of 2023 Expungement Provisions (PDF)
Act 31 of 2014 Mandated Child Abuse Recognition and Reporting
Fentanyl Safety Recommendations (PDF)
Drug Enforcement Administration (DEA) Renewal Change
Pennsylvania's Prescription Drug Monitoring Program
Naloxone Frequently Asked Questions
Naloxone Prescription for Overdose Prevention (PDF)
Naloxone for Opioid Safety - A Provider's Guide to Prescribing to Patients Who Use Opioids (PDF)
Veteran's Administration Hospitals-License Verification (PDF)
Notice - Act 65 of 2023 Expungement Provisions (PDF)
PENNDOT Physician Reporting Requirements
X-Ray Equipment Operator Refresher Training Requirement (PDF)
Certified Registered Nurse Practitioner - Death Certificates
Number of Physician Assistants Supervised by Physician (PDF)
Supervising Physician and Written Agreement Change Form updates (PDF)
Written Agreement Insurance Requirement (PDF)
National Transportation Safety Board - Safety Recommendations I-41-1 and -2 (PDF)
PA Guidelines
Guidelines for Safe Administration of Low-Dose Ketamine (PDF)
Treating Pain in Patients with OUD (PDF)
Treatment of Acute and Chronic Pain in Patients With Sickle Cell Disease (PDF)
The Safe Prescribing of Opioids in Orthopedics and Sports Medicine (PDF)
Emergency Department Pain Treatment (PDF)
Opioids to Treat Chronic Non-cancer Pain (PDF)
Geriatric Pain Treatment (PDF)
Obstetrics & Gynecology Pain Treatment (PDF)
Safe Prescribing for Workers' Compensation (PDF)
Pediatric and Adolescent Populations (PDF)